Health & Biotech
Health & Biotech
Opyl’s TrialKey achieves major milestone with potential to improve clinical trial success rates
Health & Biotech
Vida Ventures MD says it’s a rosy outlook for biotech investment in Australia in the long run
Health & Biotech
Wellnex Life raises ~$6 million, sets sights on medicinal cannabis market
Health & Biotech
ASX Biotech Stocks: Fitbit wants to sell your data to doctors and Wellnex eyes OTC medicinal cannabis product
Health & Biotech
Phase III Trials: These ASX health stocks are on the pivotal home stretch
Health & Biotech
Alzheimer’s drug no longer a moonshot as race heats up, ASX-listed Actinogen in the running
Health & Biotech
Latest clinical trials back NGS global expansion and show Healthy Heights is growing kids the right way
Health & Biotech
ASX Biotech Stocks: A big red kidney dialysis bus and Recce reduces SARS-CoV-2 in hamsters
Health & Biotech
Dimerix leading race to find treatment for slowing progression of kidney disease
Health & Biotech
Clinical Trials 101: How to spot a clinical trial with a strong chance of getting a drug to market
Health & Biotech
ASX Health Stocks: Patrys crosses brain barrier, opens up possibilities for its deoxymab antibody
Health & Biotech
ASX Health Stocks: Canada says yes to Telix, while EBR keeps market in suspense over pending announcement
Health & Biotech
Incannex jumps another hurdle to advance to Phase 2 clinical trials of its anti-inflammatory drug
Health & Biotech
Clinical Trials 101: The critical review process and getting drugs to market
Health & Biotech
ASX Biotech Stocks: This brain training app could catch dementia early and Brainchip nabs more patents
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.